Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116283937B reveals metal-free photocatalytic synthesis for high-purity aromatic secondary amines, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN114890912B reveals efficient nickel-catalyzed synthesis of fluorinated intermediates, offering cost reduction and scalable supply chain solutions for pharma.
Patent CN112574112B details a green oxidative synthesis for N-substituted 2H-indazoles. Discover cost-effective manufacturing and scalable supply chain solutions.
Advanced synthesis of p-nitrophenyl chromone spiro compounds via 1,3-dipolar cycloaddition. High purity pharmaceutical intermediates for oncology research.
Patent CN110183467B details a novel 1,3-dipolar cycloaddition route for spiro-indazole derivatives, offering cost-effective manufacturing and high purity for antitumor applications.
Patent CN116003326A details a novel Rh-catalyzed one-pot synthesis of trifluoromethyl indazoles. This method offers mild conditions, broad substrate scope, and significant cost reduction in API manufacturing.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Patent CN116396189B details a novel boron-catalyzed route for high-purity chiral intermediates, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturers.
Advanced total synthesis of 13C7-patulin via patent CN113004300A. High purity isotope standards for precise mass spectrometry quantification in agrochemical and food testing.
Patent CN111217737B details a novel Rhodium-catalyzed tandem reaction for synthesizing bioactive indane scaffolds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101440092B reveals novel CDK7 inhibitors. We offer cost-effective manufacturing and reliable supply chain solutions for these complex antitumor intermediates.
Novel phthalate condensation route offers high purity and scalable production for pharmaceutical and dye intermediates, reducing toxic solvent usage significantly.
Novel I2O5-mediated cyclization of diynes offers high-purity indanones with reduced environmental impact and simplified purification for pharmaceutical intermediates.
Patent CN113801062B reveals a novel Grignard-based route for Entrectinib intermediates, offering significant cost reduction and safer manufacturing compared to traditional Suzuki coupling methods.
Patent CN115894387A reveals a novel oxidation route for prothioconazole metabolites. Achieve 99% purity with scalable, cost-effective synthesis for residue analysis.
Patent CN101628889A reveals a high-yield toluene-based route for Donepezil key intermediates, offering significant cost and purity advantages for API manufacturers.
Novel Rh-catalyzed C-H activation for 3-aminoindanones. High yield, atom economy, scalable pharma intermediate manufacturing.
Patent CN115947690B reveals metal-free indazole synthesis with high yield. Offers cost reduction and supply chain stability for pharmaceutical intermediates manufacturing.
Novel patent CN119306612A enables high trans-selectivity. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.